Subscribe

    John Harris, MD, PhD: Developments in JAK Inhibitors for Vitiligo

    Dr. Harris discusses the recent research milestones achieved in the JAK inhibitor revolution for vitiligo and what future developments can be expected.

    More Maui Derm 2023 Video Coverage

    Sheila Fallon Friedlander, MD: Literature Update 2023 in Pediatric Dermatology

    Dr. Friedlander summarizes the most notable additions to the pediatric dermatology literature from the past year.
    PLAY

    Sheila Fallon Friedlander, MD: What’s New in Pediatric Dermatology

    xx
    PLAY

    Raj Chovatiya, MD, PhD: Exceptional Eczematous Expertise

    Dr. Chovatiya recaps his session from Maui Derm 2023, in which he took a deep dive into eczema, spongiotic dermatitis, and atopic dermatitis.
    PLAY

    Joel Cohen, MD: New Lasers for Acne Treatment

    Dr. Cohen discusses the 1726 nm laser for the treatment of acne.
    PLAY

    Joel Cohen, MD: Heavy Laser Resurfacing

    Dr. Cohen discusses his strategies for heavy laser resurfacing for a variety of cosmetic applications.

    PLAY

    Michael Gold, MD: Laser and Light Session at Maui Derm 2023

    Dr. Gold recaps his presentation from the “Lasers, Lights, Radiofrequency, Photodynamic Therapy and More” session from Maui Derm 2023.
    PLAY

    Ted Rosen, MD: What’s New in Actinic Keratoses

    Dr. Rosen discusses new methods for the treatment and prevention of actinic keratoses, including nicotinamide and a painless protocol for photodynamic therapy.
    PLAY

    Ted Rosen, MD: New Drugs and Devices at Maui Derm 2023

    Dr. Rosen recaps his New Drugs and Devices session delivered at Maui Derm 2023.
    PLAY

    Suneel Chilukuri, MD: What’s New in Toxins, Fillers, and Aesthetic Devices

    Dr. Chilukuri recaps his “What’s my Treatment?” presentation delivered at Maui Derm 2023.
    PLAY

    Dee Anna Glaser, MD: Emerging Toxins and Fillers in 2023

    Dr. Glaser discusses exciting new toxins and fillers to look out for in the coming year.
    PLAY

    Phil Werschler, MD: Cosmetic Dermatology Sessions at Maui Derm 2023

    Dr. Werschler provides an overview of the cosmetic dermatology sessions and workshops provided at Maui Derm 2023.
    PLAY

    Leon Kircik, MD: JAK Inhibitors in Dermatology

    Dr. Kircik provides an overview of the current landscape of JAK inhibitors used by dermatologists.

    PLAY

    Daniel Siegel, MD: Coding and Reimbursement

    Dr. Siegel discusses his Maui Derm 2023 presentation, “How To Maximize Your Billing Effectiveness In The Era of Dwindling Reimbursements and ICD-10
    PLAY

    Ava Shamban, MD: Improving Injection Patterns with Daxibotulinumtoxina

    Dr. Shamban recaps her Maui Derm 2023 presentation delivered during the, “What’s my Treatment?” session, in which she reported three notable cases encountered at her
    PLAY

    Lawrence Eichenfield, MD: What’s New in Pediatric Atopic Dermatitis

    Dr. Eichenfield recaps his Maui Derm 2023 presentation, in which he discusses developments in pediatric acne.
    PLAY

    Andy Blauvelt, MD, MBA: Safety Data on JAK Inhibitors for Atopic Dermatitis

    Dr. Blauvelt discusses his presentation at Maui Derm 2023, in which he compares new safety data for JAK inhibitors in atopic dermatitis treatment with data
    PLAY

    Mark Kaufmann, MD: How to Maximize Your Billing Effectiveness In The Era of Dwindling Reimbursements and ICD-10

    Dr. Kaufmann reviews his session regarding coding and reimbursement issues at the end of 2022 with hopes to better keep up with inflation in 2023.
    PLAY

    Neal Bhatia, MD: New Therapies in the Field of Dermatology

    Dr. Bhatia reviews an array of new therapies discussed during his New Drugs and Therapies presentation at Maui Derm 2023.
    PLAY

    Neal Bhatia, MD: New Opportunities for JAK Inhibitors

    Dr. Bhatia gives an overview of the utilization of JAK inhibitors in diseases such as hidradenitis suppurativa, vitiligo, alopecia areata, psoriasis, and atopic dermatitis.
    PLAY

    Neal Bhatia, MD: Ritlecitinib as an Emerging Therapy for Alopecia Areata

    Dr. Bhatia details the recent approval of Ritlecitinib which is launching soon for the treatment of alopecia areata.
    PLAY

    Matthew Zirwas, MD: Contact Dermatitis Update 2023

    Dr. Zirwas provides the main takeaways from his contact dermatitis update presentation delivered at Maui Derm 2023, including new insights into treating irritant hand dermatitis.
    PLAY

    Lawrence Eichenfield, MD: What’s New in Pediatric Acne

    Dr. Eichenfield discusses his presentation from Maui Derm 2023 that focused on developments in pediatric acne.
    PLAY
    Dr. Zirwas reviews new advancements in systemics for atopic dermatitis including JAK inhibitors and the current black box warnings for these treatments.
    PLAY

    Linda Stein Gold, MD: Exploring the Impact of Novel TYK2 Inhibitors in Plaque Psoriasis​

    Dr. Stein Gold discusses her presentation at Maui Derm 2023 which focused on new TYK2 inhibitors for the treatment of plaque psoriasis, along with other
    PLAY

    Linda Stein Gold, MD: Biggest Misconceptions Regarding Mild-to-Moderate Psoriasis​

    Dr. Stein Gold discusses various misconceptions of localized psoriasis and stresses that topical therapy remains the mainstay of treatment for this disease.
    PLAY

    Maui Derm 2023 Session Summaries

    Top Stories of 2022–2023 presented by Hensin Tsao, MD, PhD Dr. Tsao guided attendees through main takeaways from the top research in dermatology from the

    PLAY

    JCAD

    Journal of Clinical and Aesthetic Dermatology

    Facebook-f X-twitter Instagram Linkedin

    ©2025 JCAD | The Journal of Clinical and Aesthetic Dermatology. All Rights Reserved.